PROGEN Share Price Performance
SEK 0.15
-0.77 (-84.18%)
Price SEK 0.15
Share Pricen/a
Prostatype Genomics AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
PROGEN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Prostatype Genomics AB (publ) Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -0.75
- -3,401.35%
- -7,492.09%
- 20.0%
About PROGEN
- Founded
- 2007
- Employees
- 7
- CEO
- WebsiteView website
Prostatype Genomics AB (publ) manufactures, markets, and sells prognostic gene tests. The company offers a Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, gleason score, RTqPCR kit, patient database and algorithms, Prostatype Web System (PWS), and tumor stage, as well as calculates the P-score. Its test is based on a database containing prostate cancer patients; and provides decision support for patients and doctors when making a treatment decision. The company was incorporated in 2007 and is headquartered in Nacka Strand, Sweden.
